Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Lidocaine for Propofol Injection Pain
NCT07632144Not yet recruiting
- Sponsor
- Mongi Slim University Hospital
- Start
- Jun 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of ondansetron in Propofol injection pain (PIP) (3 arms), sponsored by Mongi Slim University Hospital. Primary endpoint: Incidence of pain during propofol injection. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
Propofol injection pain (PIP)
Beyond the preview
Go deeper on NCT07632144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07632144.